Kisameet Clay Isolated from the Central Coast of British Columbia, Canada, Demonstrates Broad-Spectrum Antimicrobial Activity

por Zhanel, George G., Karlowsky, James A.
Publicado 2016

Ceftazidime–avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections

por Lagacé-Wiens, Philippe, Walkty, Andrew, Karlowsky, James A
Publicado 2014

Microbiology and Preclinical Review of Omadacycline

por Karlowsky, James A, Steenbergen, Judith, Zhanel, George G
Publicado 2019

Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection

por Zhanel, George G, Walkty, Andrew J, Karlowsky, James A
Publicado 2015

Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis

por Zhanel, George G., Walkty, Andrew J., Karlowsky, James A.
Publicado 2016

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli

por Zhanel, George G., Zhanel, Michael A., Karlowsky, James A.
Publicado 2018

Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada

por Zhanel, George G., Zhanel, Michael A., Karlowsky, James A.
Publicado 2018

Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections

por Zhanel, George G., Zhanel, Michael A., Karlowsky, James A.
Publicado 2020

In Vitro Activity of Ceftibuten/VNRX-5236 against Urinary Tract Infection Isolates of Antimicrobial-Resistant Enterobacterales

por Karlowsky, James A., Hackel, Meredith A., Sahm, Daniel F.
Publicado 2022

Factors Influencing Fluoroquinolone Resistance

por Sahm, Daniel F., Thornsberry, Clyde, Jones, Mark E., Karlowsky, James A.
Publicado 2003

In Vitro Activity of Ceftibuten-Avibactam against β-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program

por Karlowsky, James A., Hackel, Meredith A., Stone, Gregory G., Sahm, Daniel F.
Publicado 2023

In vitro activity of aztreonam–avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Progr...

por Wise, Mark G., Karlowsky, James A., Mohamed, Naglaa, Kamat, Shweta, Sahm, Daniel F.
Publicado 2023

In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii-calcoaceticus Complex Collected from 2016 to 2021

por Karlowsky, James A., Hackel, Meredith A., McLeod, Sarah M., Miller, Alita A.
Publicado 2022

Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002

por Jones, Mark E, Draghi, Deborah C, Karlowsky, James A, Sahm, Daniel F, Bradley, John S
Publicado 2004

In Vitro Activity of Meropenem-Vaborbactam against Clinical Isolates of KPC-Positive Enterobacteriaceae

por Hackel, Meredith A., Lomovskaya, Olga, Dudley, Michael N., Karlowsky, James A., Sahm, Daniel F.
Publicado 2017

Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections – SMART United States 2018–2019

por Karlowsky, James A., Lob, Sibylle H., Young, Katherine, Motyl, Mary R., Sahm, Daniel F.
Publicado 2021

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including C...

por Hackel, Meredith A., Tsuji, Masakatsu, Yamano, Yoshinori, Echols, Roger, Karlowsky, James A., Sahm, Daniel F.
Publicado 2017

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in...

por Hackel, Meredith A., Tsuji, Masakatsu, Yamano, Yoshinori, Echols, Roger, Karlowsky, James A., Sahm, Daniel F.
Publicado 2018

Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19

por Zhanel, George G., Zhanel, Michael A., Boreskie, Kevin F., Lynch, Joseph P., Karlowsky, James A.
Publicado 2021

In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019

por Karlowsky, James A., Hackel, Meredith A., Takemura, Miki, Yamano, Yoshinori, Echols, Roger, Sahm, Daniel F.
Publicado 2022